STERIS plc
Insiders
Last 12 monthsSales planned on beside the trades reported on , and whether each names a .
Planned ·
$10.8M
11 notices · 43,797 sh
Oct 2025 to Oct 2026
Reported ·
$8,913,613
12 sales · 0 buys
Oct 2025 to Jun 2026
The two figures cover different periods.
4 of 12 reported sales carry the 10b5-1 box. Together they are 0.04% of the shares on issue.
under a no plan named▼ salesize is dollars
Form 144 notices, newest first
2026-08-18Breeden Richard C, Director$953,114
2026-08-12Sohi Mohsen, Director$956,779
2026-06-15Zangerle John Adam, Sr. VP, Gen Counsel, and Sec.$296,968
Form 4, 2026-06-16: sold 1,419 at $209.28 Form 4 ↗
2026-06-05Carestio Daniel A, President and CEO$291,288
2026-06-04Carestio Daniel A, President and CEO$655,511
Form 4, 2026-06-08: sold 4,428 at $213.82 Form 4 ↗
2026-06-02Breeden Richard C, Director$310,285
Form 4, 2026-06-04: sold 1,481 at $209.51 Form 4 ↗
2026-03-05FELDMANN CYNTHIA L, Director$734,867
Form 4, 2026-03-06: sold 3,098 at $237.21 Form 4 ↗
2025-11-21Madsen Julia, Sr. VP and GM, Life Sciences$1,312,096
Form 4, 2025-11-25: sold 5,008 at $262.00 Form 4 ↗
2025-11-18Tamaro Renato, V.P. & Corporate Treasurer$1,297,033
Form 4, 2025-11-20: sold 5,036 at $257.55 Form 4 ↗
2025-11-11Zangerle John Adam, Sr. VP, Gen Counsel, and Sec.$3,977,050
Form 4, 2025-11-13: sold 15,000 at $265.14 Form 4 ↗